This Article Full Text Full Text (PDF) All Versions of this Article: 24/9/1720    most recent 01.ATV.0000138072.76902.ddv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schäfer, A. Articles by Channon, K. M. Search for Related Content PubMed PubMed Citation Articles by Schäfer, A. Articles by Channon, K. M. Related Collections Other diabetes Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1720.)
© 2004 American Heart Association, Inc.

Thrombosis

Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo

Andreas Schäfer; Nicholas J. Alp; Shije Cai; Craig A. Lygate; Stefan Neubauer; Martin Eigenthaler; Johann Bauersachs; Keith M. Channon

From the Department of Cardiovascular Medicine (A.S., N.J.A., S.C., C.A.L., S.N., K.M.C.), University of Oxford, United Kingdom; and Medizinische Klinik (A.S., J.B.), Institut für Klinische Biochemie und Pathobiochemie (M.E.), Julius-Maximilians-Universität Würzburg, Germany.

Correspondence to Professor Keith M. Channon, Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. E-mail keith.channon{at}cardiov.ox.ac.uk

Objective— Platelet activation is a feature of cardiovascular disease that is also characterized by endothelial dysfunction. The direct relationship between impaired endothelium-derived NO bioavailability and platelet activation remains unclear. We investigated whether acute inhibition of NO production modulates platelet activation in mice and whether specific rescue of endothelial function in diabetes modifies platelet activation.

Methods and Results— Intravenous injection of the NO synthase inhibitor N^G-nitro-L-arginine methyl ester in wild-type (WT) mice significantly reduced platelet vasodilator-stimulated phosphoprotein (VASP) phosphorylation and increased platelet surface expression of P-selectin, CD40 ligand, and fibrinogen platelet binding, demonstrating that NO production exerts tonic inhibition of platelet activation in mice. Diabetes was induced by streptozotocin injection in WT or endothelial-targeted guanosine 5'-triphosphate cyclohydrolase I (GCH)-transgenic (GCH-Tg) mice protected from endothelial dysfunction in diabetes by sustained levels of tetrahydrobiopterin in vascular endothelium. Platelet VASP phosphorylation was significantly reduced in diabetic WT but not in diabetic GCH-Tg mice. P-selectin, CD40 ligand expression, and fibrinogen binding were increased in diabetic WT mice but remained unchanged compared with controls in endothelial-targeted GCH-Tg mice.

Conclusion— Platelet activation results from acute and chronic reduction in NO bioactivity. Rescue of platelet activation in diabetes by endothelial-specific restoration of NO production demonstrates that platelet function in vivo is principally regulated by endothelium-derived NO.

Endothelial dysfunction caused by uncoupling of endothelial NO synthase is well described in diabetes mellitus and may lead to platelet activation. Acute loss of systemic NO bioavailability causes platelet activation. eNOS uncoupling prevention in diabetes preserved systemic NO bioavailability and maintained a physiological platelet state without activation in vivo.

Key Words: diabetes • endothelial nitric oxide synthase • platelets • endothelial dysfunction

This article has been cited by other articles:

				C. Chen, H. Chai, X. Wang, J. Jiang, M. S. Jamaluddin, D. Liao, Y. Zhang, H. Wang, U. Bharadwaj, S. Zhang, et al. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells Blood, October 15, 2008; 112(8): 3205 - 3216. [Abstract] [Full Text] [PDF]

				X. Liu, P. Srinivasan, E. Collard, P. Grajdeanu, J. L. Zweier, and A. Friedman Nitric Oxide Diffusion Rate is Reduced in the Aortic Wall Biophys. J., March 1, 2008; 94(5): 1880 - 1889. [Abstract] [Full Text] [PDF]

				A. Schafer, U. Flierl, A. Kobsar, M. Eigenthaler, G. Ertl, and J. Bauersachs Soluble Guanylyl Cyclase Activation With HMR1766 Attenuates Platelet Activation in Diabetic Rats Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2813 - 2818. [Abstract] [Full Text] [PDF]

				A. Schafer, D. Fraccarollo, M. Eigenthaler, P. Tas, A. Firnschild, S. Frantz, G. Ertl, and J. Bauersachs Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of NO Bioavailability Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1071 - 1077. [Abstract] [Full Text] [PDF]